Post-massive Weight Loss Chest Contouring: Inferior Pedicle Technique in Pseudo-gynecomastia Correction

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Completed
CT.gov ID
NCT03319862
Collaborator
(none)
28
1
11.6
2.4

Study Details

Study Description

Brief Summary

The massive weight loss leads an important excess of skin on thoracic level giving the aspect of a feminine breast with a relatively important ptose. Several techniques were described in the literature about gynaecomastia , but the post-bariatric pseudo-gynaecomastia was not handled yet enough. Moreover, there is no single consensual technique on this subject. The technique used in this service was described for the first time in 2008 ( 1 ) on a serie of 8 patients with an average follow-up of 13 months. Although the results are promising, no other publication was done, and the procedure remains badly represented in the world literature.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Inferior pédicule gynaecomastia

Study Design

Study Type:
Observational
Actual Enrollment :
28 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Post-massive Weight Loss Chest Contouring: Inferior Pedicle Technique in Pseudo-gynecomastia Correction
Actual Study Start Date :
Nov 14, 2016
Actual Primary Completion Date :
Sep 30, 2017
Actual Study Completion Date :
Nov 2, 2017

Outcome Measures

Primary Outcome Measures

  1. aesthetic result score [Average of 6 months post-surgery]

    patient answer to a satisfaction questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • inferior pedicle gynaecomastia surgery

  • Age > 16

Exclusion Criteria:
  • Age < 16

Contacts and Locations

Locations

Site City State Country Postal Code
1 Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France France 75014

Sponsors and Collaborators

  • Groupe Hospitalier Paris Saint Joseph

Investigators

  • Study Director: Philippe LEVAN, MD, GHPSJ

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Groupe Hospitalier Paris Saint Joseph
ClinicalTrials.gov Identifier:
NCT03319862
Other Study ID Numbers:
  • PEDINF
First Posted:
Oct 24, 2017
Last Update Posted:
Mar 1, 2018
Last Verified:
Oct 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 1, 2018